1887

Abstract

The identification of specific genetic changes associated with differences in the pathogenicity of Marek's disease virus strains (GaHV-2) has been a formidable task due to the large number of mutations in mixed-genotype populations within DNA preparations. Very virulent UK isolate C12/130 induces extensive lymphoid atrophy, neurological manifestations and early mortality in young birds. We have recently reported the construction of several independent full-length bacterial artificial chromosome (BAC) clones of C12/130 capable of generating fully infectious viruses with significant differences in their pathogenicity profiles. Two of these clones (vC12/130-10 and vC12/130-15), which showed differences in virulence relative to each other and to the parental strain, had similar replication kinetics both and in spite of the fact that vC12/130-15 was attenuated. To investigate the possible reasons for this, the nucleotide sequences of both clones were determined. Sequence analysis of the two genomes identified mutations within eight genes. A single 494 bp insertion was identified within the genome of the virulent vC12/130-10 clone. Seven non-synonymous substitutions distinguished virulent vC12/130-10 from that of attenuated vC12/130-15. By sequencing regions of parental DNA that differed between the two BAC clones, we confirmed that C12/130 does contain these mutations in varying proportions. Since the individual reconstituted BAC clones were functionally attenuated and derived from a single DNA source of phenotypically very virulent C12/130, this suggests that the C12/130 virus population exists as a collection of mixed genotypes.

Loading

Article metrics loading...

/content/journal/jgv/10.1099/vir.0.027706-0
2011-07-01
2020-01-24
Loading full text...

Full text loading...

/deliver/fulltext/jgv/92/7/1500.html?itemId=/content/journal/jgv/10.1099/vir.0.027706-0&mimeType=html&fmt=ahah

References

  1. Baigent S. J., Petherbridge L. J., Howes K., Smith L. P., Currie R. J., Nair V. K.. ( 2005;). Absolute quantitation of Marek's disease virus genome copy number in chicken feather and lymphocyte samples using real-time PCR. . J Virol Methods 123:, 53–64. [CrossRef].[PubMed]
    [Google Scholar]
  2. Barrow A., Venugopal K.. ( 1999;). Molecular characteristics of very virulent European MDV isolates. . Acta Virol 43:, 90–93.[PubMed]
    [Google Scholar]
  3. Barrow A. D., Burgess S. C., Baigent S. J., Howes K., Nair V. K.. ( 2003;a). Infection of macrophages by a lymphotropic herpesvirus: a new tropism for Marek's disease virus. . J Gen Virol 84:, 2635–2645. [CrossRef].[PubMed]
    [Google Scholar]
  4. Barrow A. D., Burgess S. C., Howes K., Nair V. K.. ( 2003;b). Monocytosis is associated with the onset of leukocyte and viral infiltration of the brain in chickens infected with the very virulent Marek's disease virus strain C12/130. . Avian Pathol 32:, 183–191. [CrossRef].[PubMed]
    [Google Scholar]
  5. Calnek B. W.. ( 2001;). Pathogenesis of Marek's disease virus infection. . Curr Top Microbiol Immunol 255:, 25–55.
    [Google Scholar]
  6. Corpet F.. ( 1988;). Multiple sequence alignment with hierarchical clustering. . Nucleic Acids Res 16:, 10881–10890. [CrossRef].[PubMed]
    [Google Scholar]
  7. Edgar R. C.. ( 2004;). muscle: multiple sequence alignment with high accuracy and high throughput. . Nucleic Acids Res 32:, 1792–1797. [CrossRef].[PubMed]
    [Google Scholar]
  8. Goodman L. B., Loregian A., Perkins G. A., Nugent J., Buckles E. L., Mercorelli B., Kydd J. H., Palù G., Smith K. C. et al. ( 2007;). A point mutation in a herpesvirus polymerase determines neuropathogenicity. . PLoS Pathog 3:, e160. [CrossRef].[PubMed]
    [Google Scholar]
  9. Heinemeyer T., Wingender E., Reuter I., Hermjakob H., Kel A. E., Kel O. V., Ignatieva E. V., Ananko E. A., Podkolodnaya O. A. et al. ( 1998;). Databases on transcriptional regulation: TRANSFAC, TRRD and COMPEL. . Nucleic Acids Res 26:, 362–367. [CrossRef].[PubMed]
    [Google Scholar]
  10. Heinemeyer T., Chen X., Karas H., Kel A. E., Kel O. V., Liebich I., Meinhardt T., Reuter I., Schacherer F., Wingender E.. ( 1999;). Expanding the TRANSFAC database towards an expert system of regulatory molecular mechanisms. . Nucleic Acids Res 27:, 318–322. [CrossRef].[PubMed]
    [Google Scholar]
  11. Isfort R. J., Qian Z., Jones D., Silva R. F., Witter R., Kung H. J.. ( 1994;). Integration of multiple chicken retroviruses into multiple chicken herpesviruses: herpesviral gD as a common target of integration. . Virology 203:, 125–133. [CrossRef].[PubMed]
    [Google Scholar]
  12. Jones D., Isfort R., Witter R., Kost R., Kung H. J.. ( 1993;). Retroviral insertions into a herpesvirus are clustered at the junctions of the short repeat and short unique sequences. . Proc Natl Acad Sci U S A 90:, 3855–3859. [CrossRef].[PubMed]
    [Google Scholar]
  13. Katoh K., Kuma K., Toh H., Miyata T.. ( 2005;). MAFFT version 5: improvement in accuracy of multiple sequence alignment. . Nucleic Acids Res 33:, 511–518. [CrossRef].[PubMed]
    [Google Scholar]
  14. Kumar S., Tamura K., Nei M.. ( 2004;). mega3: Integrated software for Molecular Evolutionary Genetics Analysis and sequence alignment. . Brief Bioinform 5:, 150–163. [CrossRef].[PubMed]
    [Google Scholar]
  15. Lee L. F., Kieff E. D., Bachenheimer S. L., Roizman B., Spear P. G., Burmester B. R., Nazerian K.. ( 1971;). Size and composition of Marek's disease virus deoxyribonucleic acid. . J Virol 7:, 289–294.[PubMed]
    [Google Scholar]
  16. Lee L. F., Wu P., Sui D., Ren D., Kamil J., Kung H. J., Witter R. L.. ( 2000;). The complete unique long sequence and the overall genomic organization of the GA strain of Marek's disease virus. . Proc Natl Acad Sci U S A 97:, 6091–6096. [CrossRef].[PubMed]
    [Google Scholar]
  17. Maray T., Malkinson M., Becker Y.. ( 1988;). RNA transcripts of Marek's disease virus (MDV) serotype-1 in infected and transformed cells. . Virus Genes 2:, 49–68. [CrossRef].[PubMed]
    [Google Scholar]
  18. Margulies M., Egholm M., Altman W. E., Attiya S., Bader J. S., Bemben L. A., Berka J., Braverman M. S., Chen Y. J. et al. ( 2005;). Genome sequencing in microfabricated high-density picolitre reactors. . Nature 437:, 376–380.[PubMed]
    [Google Scholar]
  19. Niikura M., Dodgson J., Cheng H.. ( 2006;). Direct evidence of host genome acquisition by the alphaherpesvirus Marek's disease virus. . Arch Virol 151:, 537–549. [CrossRef].[PubMed]
    [Google Scholar]
  20. Nugent J., Birch-Machin I., Smith K. C., Mumford J. A., Swann Z., Newton J. R., Bowden R. J., Allen G. P., Davis-Poynter N.. ( 2006;). Analysis of equid herpesvirus 1 strain variation reveals a point mutation of the DNA polymerase strongly associated with neuropathogenic versus nonneuropathogenic disease outbreaks. . J Virol 80:, 4047–4060. [CrossRef].[PubMed]
    [Google Scholar]
  21. Osterrieder K., Vautherot J.-F.. ( 2004;). The Genome Content of Marek's Disease-Like Viruses. Marek's Disease:an Emerging Problem. Oxford, UK:: Elsevier;.
    [Google Scholar]
  22. Peng Q., Shirazi Y.. ( 1996;a). Characterization of the protein product encoded by a splicing variant of the Marek's disease virus Eco-Q gene (Meq). . Virology 226:, 77–82. [CrossRef].[PubMed]
    [Google Scholar]
  23. Peng Q., Shirazi Y.. ( 1996;b). Isolation and characterization of Marek's disease virus (MDV) cDNAs from a MDV-transformed lymphoblastoid cell line: identification of an open reading frame antisense to the MDV Eco-Q protein (Meq). . Virology 221:, 368–374. [CrossRef].[PubMed]
    [Google Scholar]
  24. Peng Q., Zeng M., Bhuiyan Z. A., Ubukata E., Tanaka A., Nonoyama M., Shirazi Y.. ( 1995;). Isolation and characterization of Marek's disease virus (MDV) cDNAs mapping to the BamHI-I2, BamHI-Q2, and BamHI-L fragments of the MDV genome from lymphoblastoid cells transformed and persistently infected with MDV. . Virology 213:, 590–599. [CrossRef].[PubMed]
    [Google Scholar]
  25. Petherbridge L., Brown A. C., Baigent S. J., Howes K., Sacco M. A., Osterrieder N., Nair V. K.. ( 2004;). Oncogenicity of virulent Marek's disease virus cloned as bacterial artificial chromosomes. . J Virol 78:, 13376–13380. [CrossRef].[PubMed]
    [Google Scholar]
  26. Quinlivan M., Gershon A. A., Steinberg S. P., Breuer J.. ( 2005;). An evaluation of single nucleotide polymorphisms used to differentiate vaccine and wild type strains of varicella-zoster virus. . J Med Virol 75:, 174–180. [CrossRef].[PubMed]
    [Google Scholar]
  27. Quinlivan M., Gershon A. A., Al Bassam M. M., Steinberg S. P., LaRussa P., Nichols R. A., Breuer J.. ( 2007;). Natural selection for rash-forming genotypes of the varicella-zoster vaccine virus detected within immunized human hosts. . Proc Natl Acad Sci U S A 104:, 208–212. [CrossRef].[PubMed]
    [Google Scholar]
  28. Roizman B., Carmichael L. E., Deinhardt F., de-The G., Nahmias A. J., Plowright W., Rapp F., Sheldrick P., Takahashi M., Wolf K.. ( 1981;). Herpesviridae. Definition, provisional nomenclature, and taxonomy. The Herpesvirus Study Group, the International Committee on Taxonomy of Viruses. . Intervirology 16:, 201–217. [CrossRef].[PubMed]
    [Google Scholar]
  29. Schäffer A. A., Aravind L., Madden T. L., Shavirin S., Spouge J. L., Wolf Y. I., Koonin E. V., Altschul S. F.. ( 2001;). Improving the accuracy of psi-blast protein database searches with composition-based statistics and other refinements. . Nucleic Acids Res 29:, 2994–3005. [CrossRef].[PubMed]
    [Google Scholar]
  30. Schwyzer M., Fischer-Bracher C., Fraefel C., Bächi T., Nuñez R., Engels M., Ackermann M.. ( 2002;). Transduction of Vero cells and bovine monocytes with a herpes simplex virus-1 based amplicon carrying the gene for the bovine herpesvirus-1 Circ protein. . Vet Microbiol 86:, 165–174. [CrossRef].[PubMed]
    [Google Scholar]
  31. Smith L. P., Petherbridge L. J., Baigent S. J., Simpson J., Nair V.. ( 2011;). Pathogenicity of a very virulent strain of Marek's disease herpesvirus cloned as infectious bacterial artificial chromosomes. . J Biomed Biotechnol 2011:, 412829. [CrossRef].[PubMed]
    [Google Scholar]
  32. Spatz S. J.. ( 2010;). Accumulation of attenuating mutations in varying proportions within a high passage very virulent plus strain of Gallid herpesvirus type 2. . Virus Res 149:, 135–142. [CrossRef].[PubMed]
    [Google Scholar]
  33. Spatz S. J., Rue C. A.. ( 2008;). Sequence determination of a mildly virulent strain (CU-2) of Gallid herpesvirus type 2 using 454 pyrosequencing. . Virus Genes 36:, 479–489. [CrossRef].[PubMed]
    [Google Scholar]
  34. Spatz S. J., Silva R. F.. ( 2007;a). Polymorphisms in the repeat long regions of oncogenic and attenuated pathotypes of Marek's disease virus 1. . Virus Genes 35:, 41–53. [CrossRef].[PubMed]
    [Google Scholar]
  35. Spatz S. J., Silva R. F.. ( 2007;b). Sequence determination of variable regions within the genomes of gallid herpesvirus-2 pathotypes. . Arch Virol 152:, 1665–1678. [CrossRef].[PubMed]
    [Google Scholar]
  36. Spatz S. J., Petherbridge L., Zhao Y., Nair V.. ( 2007;). Comparative full-length sequence analysis of oncogenic and vaccine (Rispens) strains of Marek's disease virus. . J Gen Virol 88:, 1080–1096. [CrossRef].[PubMed]
    [Google Scholar]
  37. Spatz S. J., Rue C., Schumacher D., Osterrieder N.. ( 2008;). Clustering of mutations within the inverted repeat regions of a serially passaged attenuated gallid herpesvirus type 2 strain. . Virus Genes 37:, 69–80. [CrossRef].[PubMed]
    [Google Scholar]
  38. Tian M., Zhao Y., Shi M., Lin Y., Zou N., Liu P., Wen X., Cao S., Huang Y.. ( 2010;). A novel protein-coding ORF72.2 gene was identified from Marek's disease virus strain CVI988. . Virol J 7:, 371. [CrossRef].[PubMed]
    [Google Scholar]
  39. Tulman E. R., Afonso C. L., Lu Z., Zsak L., Rock D. L., Kutish G. F.. ( 2000;). The genome of a very virulent Marek's disease virus. . J Virol 74:, 7980–7988. [CrossRef].[PubMed]
    [Google Scholar]
  40. Volkening J. D., Spatz S. J.. ( 2009;). Purification of DNA from the cell-associated herpesvirus Marek's disease virus for 454 pyrosequencing using micrococcal nuclease digestion and polyethylene glycol precipitation. . J Virol Methods 157:, 55–61. [CrossRef].[PubMed]
    [Google Scholar]
  41. Witter R. L.. ( 1997;). Increased virulence of Marek's disease virus field isolates. . Avian Dis 41:, 149–163. [CrossRef].[PubMed]
    [Google Scholar]
  42. Witter R. L.. ( 2001a;). Marek's disease virus vaccines-past, present and future (chicken vs. virus-a battle of the centuries). Current progression Marek's disease research. . In Proceedings of the 6th International Symposium on Marek's disease. Schat K. A., Morgan R. M., Parcells M. S., Spencer J. L... Kennett Square, PA:: American Association of Avian Pathologists;.
    [Google Scholar]
  43. Witter R. L.. ( 2001b;). Protective efficacy of Marek's disease vaccines. . Curr Top Microbiol Immunol 255:, 57–90.
    [Google Scholar]
  44. Zhao Y., Petherbridge L., Smith L. P., Baigent S., Nair V.. ( 2008;). Self-excision of the BAC sequences from the recombinant Marek's disease virus genome increases replication and pathogenicity. . Virol J 5:, 19. [CrossRef].[PubMed]
    [Google Scholar]
http://instance.metastore.ingenta.com/content/journal/jgv/10.1099/vir.0.027706-0
Loading
/content/journal/jgv/10.1099/vir.0.027706-0
Loading

Data & Media loading...

Most cited articles

This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error